Ambrx Biopharma Operating Margin vs. Shares Outstanding

AMAMDelisted Stock  USD 15.73  0.71  4.73%   
Based on the key profitability measurements obtained from Ambrx Biopharma's financial statements, Ambrx Biopharma American may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Ambrx Biopharma's ability to earn profits and add value for shareholders.
For Ambrx Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ambrx Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ambrx Biopharma American utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ambrx Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ambrx Biopharma American over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between Ambrx Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ambrx Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ambrx Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ambrx Biopharma American Shares Outstanding vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ambrx Biopharma's current stock value. Our valuation model uses many indicators to compare Ambrx Biopharma value to that of its competitors to determine the firm's financial worth.
Ambrx Biopharma American is rated fifth in operating margin category among its peers. It is rated below average in shares outstanding category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Ambrx Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ambrx Shares Outstanding vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Ambrx Biopharma

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(483.51) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Ambrx Biopharma

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
63.29 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Ambrx Shares Outstanding Comparison

Ambrx Biopharma is currently under evaluation in shares outstanding category among its peers.

Ambrx Biopharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Ambrx Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ambrx Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of Ambrx Biopharma's change in net profit over the period of time. It can combine multiple indicators of Ambrx Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. The company was incorporated in 2003 and is headquartered in La Jolla, California. Ambrx Biopharma operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 81 people.

Ambrx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ambrx Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ambrx Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ambrx Biopharma's important profitability drivers and their relationship over time.

Use Ambrx Biopharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ambrx Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambrx Biopharma will appreciate offsetting losses from the drop in the long position's value.

Ambrx Biopharma Pair Trading

Ambrx Biopharma American Pair Trading Analysis

The ability to find closely correlated positions to Ambrx Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ambrx Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ambrx Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ambrx Biopharma American to buy it.
The correlation of Ambrx Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ambrx Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ambrx Biopharma American moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ambrx Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Ambrx Biopharma position

In addition to having Ambrx Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Petroleum and Natural Gas Thematic Idea Now

Petroleum and Natural Gas
Petroleum and Natural Gas Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Ambrx Stock

If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like